|
|||||
|
|
Immediate effects of the initial FDA notification on the use of surgical mesh for pelvic organ prolapse surgery in medicare beneficiaries |
|
| Authors: | W. Stuart Reynolds Karen P. Gold Shenghua Ni Melissa R. Kaufman Roger R. Dmochowski David F. Penson |
| Affiliation: | 1. Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee;2. Department of Obstetrics & Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee;3. Institute for Medicine and Public Health, Vanderbilt University Medical Center, Nashville, Tennessee;4. Veterans Affairs, Tennessee Valley Geriatric Research Education and Clinical Centers, Nashville, Tennessee |
| Abstract: | |
| Keywords: | pelvic organ prolapse surgical mesh U.S. Food and Drug Administration U.S. Medicare program |